These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10160477)

  • 21. Recurrent vulvovaginal candidiasis: A review of guideline recommendations.
    Matheson A; Mazza D
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):139-145. PubMed ID: 28299777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic vulvovaginal candidiasis.
    Retzer DR
    N Engl J Med; 2004 Dec; 351(24):2554-6; author reply 2554-6. PubMed ID: 15599956
    [No Abstract]   [Full Text] [Related]  

  • 23. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database.
    Mårdh PA; Wågström J; Landgren M; Holmén J
    Infect Dis Obstet Gynecol; 2004 Jun; 12(2):91-7. PubMed ID: 15739823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.
    Chew SY; Than LT
    Mycoses; 2016 May; 59(5):262-73. PubMed ID: 26765516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.
    Sherry L; Kean R; McKloud E; O'Donnell LE; Metcalfe R; Jones BL; Ramage G
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
    van Schalkwyk J; Yudin MH;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial management of recurrent vulvovaginal candidiasis with oral ketoconazole and topical clotrimazole.
    Sobel JD; Schmitt C; Stein G; Mummaw N; Christensen S; Meriwether C
    J Reprod Med; 1994 Jul; 39(7):517-20. PubMed ID: 7966041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vulvovaginal candidiasis: a current update.
    Carcio HA; Secor RM
    Nurse Pract Forum; 1992 Sep; 3(3):135-44. PubMed ID: 1472885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment options for vulvovaginal candidiasis, 1993.
    Reef SE; Levine WC; McNeil MM; Fisher-Hoch S; Holmberg SD; Duerr A; Smith D; Sobel JD; Pinner RW
    Clin Infect Dis; 1995 Apr; 20 Suppl 1():S80-90. PubMed ID: 7795112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of chronic vulvovaginal candidiasis: a long term retrospective study.
    Nguyen Y; Lee A; Fischer G
    Australas J Dermatol; 2017 Nov; 58(4):e188-e192. PubMed ID: 27250078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in prescribing for vulvovaginal candidiasis in the United States.
    McCaig LF; McNeil MM
    Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):113-20. PubMed ID: 15386715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vulvovaginal candidiasis: a therapeutic approach].
    Battaglia F; Mariani L; Anglana F; Milite V; Quattrini M; Plotti F; Tomao F; Plotti G
    Minerva Ginecol; 2005 Apr; 57(2):131-9. PubMed ID: 15940073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
    Ray D; Goswami R; Dadhwal V; Goswami D; Banerjee U; Kochupillai N
    J Infect; 2007 Oct; 55(4):374-7. PubMed ID: 17692922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC).
    Watson MC; Bond CM;
    Pharm World Sci; 2003 Aug; 25(4):129-34. PubMed ID: 12964489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic vulvovaginal candidiasis in patients using a levonorgestrel-containing intrauterine device.
    Nguyen Y; Fischer G
    Australas J Dermatol; 2018 Feb; 59(1):e39-e42. PubMed ID: 27957732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genital candidiasis].
    Ono F; Yasumoto S
    Nihon Rinsho; 2009 Jan; 67(1):157-61. PubMed ID: 19177766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global burden of recurrent vulvovaginal candidiasis: a systematic review.
    Denning DW; Kneale M; Sobel JD; Rautemaa-Richardson R
    Lancet Infect Dis; 2018 Nov; 18(11):e339-e347. PubMed ID: 30078662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Short-course treatment of vulvovaginal candidiasis: comparative study of fluconazole and intra-vaginal fenticonazole].
    Murina F; Graziottin A; Felice R; Di Francesco S; Mantegazza V
    Minerva Ginecol; 2012 Apr; 64(2):89-94. PubMed ID: 22481619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
    De Seta F; Parazzini F; De Leo R; Banco R; Maso GP; De Santo D; Sartore A; Stabile G; Inglese S; Tonon M; Restaino S
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():136-9. PubMed ID: 25305660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of vaginal colonization by drug-resistant Candida species in college-age women with previous exposure to over-the-counter azole antifungals.
    Mathema B; Cross E; Dun E; Park S; Bedell J; Slade B; Williams M; Riley L; Chaturvedi V; Perlin DS
    Clin Infect Dis; 2001 Sep; 33(5):E23-7. PubMed ID: 11477529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.